Join Our Educational Webinar
“Biologics & The Law: Navigate 6 High-Risk Zones”
Tuesday, December 16th, 2025, 7 PM EST
The regulatory landscape for human-derived biologic products (including exosomes, Wharton’s Jelly, and related therapeutics) is under unprecedented scrutiny from the FDA and state FSMBs. What was once considered a “gray area” has been classified as a “high-risk zone” for legal exposure. This session provides the essential, evidence-based regulatory context required to protect your practice and license.
Join Our Educational Webinar
“Business Implementation of Biologics in a Cash-Pay Practice”
Wednesday, April 30th, 2025, 7 PM EST
Ready to scale your practice with natural biologics—without relying on insurance?
This business-focused webinar is for providers who want to turn clinical knowledge into actionable strategy. Learn how to build a compliant, profitable cash-pay model using natural biologic products. Our experts will walk you through the proven “Learn, Launch, Liberate” roadmap and show you how to use education to make science-based, informed decisions in both aesthetics and advanced pain care.
What You’ll Learn:
What You’ll Learn:
Product Definition and Sourcing: Understand why products derived from human tissue are currently treated as unapproved drugs and how to manage the legal risk of product sourcing.
Informed Consent Standards: Dissect the mandatory components for obtaining compliant informed consent as defined by the Federation of State Medical Boards (FSMB).
Communication Audits: Learn the specific communication standards required for marketing and patient education to mitigate risk associated with provider-use biologic manufacturing.
The Unsubstantiated Claim Trap: Identify and eliminate language that regulators classify as high-risk claims of “clarity” or “protection”.
Speakers
Speakers
Brooke Morrisseau
CEO/Founder Ggevityy
Ben Campbell,
CRNA
Ed Weeks Jr.
MBA
If you wait, you risk being caught relying on outdated compliance knowledge. Don’t delay your defense. Register now to secure the clear, evidence-based roadmap your practice requires.
